Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021

SELL
$2.62 - $3.45 $76,737 - $101,047
-29,289 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$1.96 - $3.15 $200,153 - $321,674
-102,119 Reduced 77.71%
29,289 $92,000
Q1 2021

May 06, 2021

BUY
$1.89 - $2.96 $115,329 - $180,622
61,021 Added 86.69%
131,408 $280,000
Q4 2020

Feb 09, 2021

BUY
$0.65 - $1.94 $45,751 - $136,550
70,387 New
70,387 $137,000

Others Institutions Holding VTGN

About VistaGen Therapeutics, Inc.


  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $701M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.